Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Tuberculosis and CYP2A6[original query] |
|---|
| Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study. BMC infectious diseases 2013 13 261. Mukonzo Jackson K, Okwera Alphonse, Nakasujja Neoline, Luzze Henry, Sebuwufu Deogratious, Ogwal-Okeng Jasper, Waako Paul, Gustafsson Lars L, Aklillu Ele |
| The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patients. Antiviral research 2013 Dec . Bienvenu E, Swart M, Dandara C, Ashton M |
| Genetic variants of drug metabolizing enzymes and drug transporter (ABCB1) as possible biomarkers for adverse drug reactions in an HIV/AIDS cohort in Zimbabwe. Current HIV research 2013 Sep 11 (6): 481-90. Dhoro Milcah, Ngara Bernard, Kadzirange Gerald, Nhachi Charles, Masimirembwa Coll |
| Efavirenz dosing: influence of drug metabolizing enzyme polymorphisms and concurrent tuberculosis treatment. Antiviral therapy 2015 20 (3): 297-306. Gengiah Tanuja N, Botha Julia H, Yende-Zuma Nonhlanhla, Naidoo Kogieleum, Abdool Karim Salim |
| Pharmacogenetic predictors of nevirapine pharmacokinetics in Ghanaian children living with HIV with or without TB coinfection. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2021 4 92 104856. Langaee Taimour, Al-Shaer Mohammad H, Gong Yan, Lima Elizabeth, Antwi Sampson, Enimil Anthony, Dompreh Albert, Yang Hongmei, Alghamdi Wael A, Wiesner Lubbe, Peloquin Charles A, Kwara Awewu |
- Page last reviewed:Feb 1, 2024
- Content source: